NYU Langone Medical Center and RTsafe P.C. are collaborating on a research project for the potential dosimetric validation of mask‐based radiosurgery using pseudo‐in‐vivo 3D dosimetry and ion chamber phantoms, developed by RTsafe.

We are pleased to announce that RTsafe is one of the thirteen European high-growth startup companies selected for the European Healthcare Startup Investment Mission to the US organized under the aegis of the U.S. Department of Commerce.

RTsafe is proud to announce the launching of its strategic partnership with the Department of Experimental Physics – Medical Physics at LMU Munich, Germany.